rs749320057
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_007289.4(MME):c.467delC(p.Pro156LeufsTer14) variant causes a frameshift change. The variant allele was found at a frequency of 0.000326 in 1,612,842 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_007289.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 62AN: 151872Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000260 AC: 65AN: 250084Hom.: 0 AF XY: 0.000214 AC XY: 29AN XY: 135422
GnomAD4 exome AF: 0.000318 AC: 464AN: 1460970Hom.: 0 Cov.: 31 AF XY: 0.000307 AC XY: 223AN XY: 726690
GnomAD4 genome AF: 0.000408 AC: 62AN: 151872Hom.: 0 Cov.: 32 AF XY: 0.000485 AC XY: 36AN XY: 74156
ClinVar
Submissions by phenotype
not provided Pathogenic:9
MME: PVS1, PP1:Strong -
Reported to segregate with disease in two unrelated families with autosomal dominant late-onset peripheral neuropathy (Auer-Grumbach et al., 2016); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25565308, 34758253, 15464186, 27588448, 30415211, 31974930, 34307994, 31589614, 33726816, 32345996, 31429185, 20692264, 35318247) -
- -
PP1_strong, PM3_strong, PS3_supporting, PS4, PVS1 -
- -
- -
- -
This sequence change creates a premature translational stop signal (p.Pro156Leufs*14) in the MME gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MME are known to be pathogenic (PMID: 26991897). This variant is present in population databases (rs749320057, gnomAD 0.07%). This premature translational stop signal has been observed in individual(s) with late-onset axonal Charcot-Marie-Tooth disease, and alloimmune antenatal membranous nephropathy (PMID: 15464186, 25565308, 27588448). ClinVar contains an entry for this variant (Variation ID: 426945). For these reasons, this variant has been classified as Pathogenic. -
- -
Charcot-Marie-Tooth disease axonal type 2T Pathogenic:5Other:1
- -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.025%). Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000426945 / PMID: 15464186 / 3billion dataset). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Variant summary: MME c.467delC (p.Pro156LeufsX14) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 0.00026 in 250084 control chromosomes (gnomAD). c.467delC has been reported in the literature in multiple individuals affected with Charcot-Marie Disease Axonal Type 2T (Hoyer_2022). These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 35318247). ClinVar contains an entry for this variant (Variation ID: 426945). Based on the evidence outlined above, the variant was classified as pathogenic. -
_x000D_ Criteria applied: PVS1, PS4_SUP, PP1 -
- -
Charcot-Marie-Tooth disease type 2T Pathogenic:1
This sequence change in MME is a frameshift variant predicted to cause a premature stop codon, p.(Pro156Leufs*14), in biologically relevant exon 6/23 leading to nonsense-mediated decay in a gene in which loss of function is an established disease mechanism (PMID: 33144514, 27588448). The highest population minor allele frequency in the population database gnomAD v2.1 is 0.07% (25/35,256 alleles) in the Latino/Admixed American population. This variant has been reported in the context of both recessive and dominant (dominant risk factor with incomplete penetrance) inheritance patterns for Charcot-Marie-Tooth (CMT) disease (PMID: 33144514). The variant has been reported to segregate with CMT in multiple families with evidence for semi-dominant inheritance (PMID: 27588448, 33144514, 35318247). A significant reduction in neprilysin levels has been reported in the adipose tissue and blood plasma of heterozygous carriers compared to controls (PMID: 27588448). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1, PP1_Strong. -
Charcot-Marie-Tooth disease axonal type 2T;C4310763:Spinocerebellar ataxia 43 Pathogenic:1
- -
See cases Pathogenic:1
ACMG categories: PVS1,PS3,PS4 -
Spinocerebellar ataxia 43 Pathogenic:1
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM1,PP5. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at